Non-Executive Director Timothy Bunting Just Bought 5.3% More Shares In Oncimmune Holdings plc (LON:ONC)

Investors who take an interest in Oncimmune Holdings plc (LON:ONC) should definitely note that the Non-Executive Director, Timothy Bunting, recently paid UK£1.19 per share to buy UK£179k worth of the stock. Although the purchase only increased their holding by 5.3%, it is still a solid purchase in our view.

Check out our latest analysis for Oncimmune Holdings

The Last 12 Months Of Insider Transactions At Oncimmune Holdings

Notably, that recent purchase by Timothy Bunting is the biggest insider purchase of Oncimmune Holdings shares that we've seen in the last year. So it's clear an insider wanted to buy, at around the current price, which is UK£1.34. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. In this case we're pleased to report that the insider purchases were made at close to current prices.

In the last twelve months insiders purchased 273.50k shares for UK£262k. On the other hand they divested 25000 shares, for UK£18k. In the last twelve months there was more buying than selling by Oncimmune Holdings insiders. The average buy price was around UK£0.96. To my mind it is good that insiders have invested their own money in the company. However, you should keep in mind that they bought when the share price was meaningfully below today's levels. The chart below shows insider transactions (by individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

AIM:ONC Recent Insider Trading June 7th 2020
AIM:ONC Recent Insider Trading June 7th 2020

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Does Oncimmune Holdings Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Oncimmune Holdings insiders own about UK£14m worth of shares. That equates to 17% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

So What Does This Data Suggest About Oncimmune Holdings Insiders?

It's certainly positive to see the recent insider purchases. And the longer term insider transactions also give us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Given that insiders also own a fair bit of Oncimmune Holdings we think they are probably pretty confident of a bright future. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 3 warning signs for Oncimmune Holdings (2 don't sit too well with us!) that we believe deserve your full attention.

Of course Oncimmune Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.